Skip to main content
Clinical Trials/NCT01489436
NCT01489436CompletedNot Applicable

Comparative Effectiveness of Novel Minimally Invasive Procedures

Mayo Clinic1 site in 1 country118 target enrollmentStarted: July 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
118
Locations
1
Primary Endpoint
Pain Scores on the Visual Analog Scale

Study Overview

Brief Summary

New minimally invasive surgical treatments are often outpatient procedures with low complication rates, promising fast recovery. The traditional physician-reported outcomes such as complication rates, blood loss, and hospital stay are not useful to guide treatment recommendations for one or the other minimally invasive procedure. This study aims to apply patient-reported outcomes developed within the NIH framework for cancer research and chronic disease treatment to the comparative effectiveness research in minimally invasive procedures for benign disease.

Detailed Description

To establish a pathway for comparative effectiveness using patient reported outcomes in minimally invasive surgery, we propose to use a readily available and easily reproducible model: cholecystectomy. Each year in the United States, approximately 750,000 patients undergo a cholecystectomy. Patients clearly prefer the laparoscopic approach over the open procedure to abdominal surgery. Initial survey data suggest that patients may also prefer even less invasive approaches.

Currently, the standard operative procedure for a patient with symptomatic gallstone disease is a laparoscopic cholecystectomy performed under general anesthesia with four small abdominal incisions. Although postoperative pain and cardiopulmonary and wound complications are much less compared to open cholecystectomy, considerable cost is generated from lost productivity in days off of work after the surgical procedure related in part to pain and the physiologic response to the stress of the operative procedure. Anecdotal data suggest that fewer incisions, especially fewer transabdominal incisions, translate into less pain, less need for narcotic pain medication and faster recovery, but randomized trial data are needed. We propose to compare the effectiveness of the novel single-port cholecystectomy with laparoscopic cholecystectomy, the current standard of care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •for this study are:
  • •patients undergoing cholecystectomy in an elective setting for symptomatic gallstone disease.

Exclusion Criteria

  • •for the study are:
  • •Patients <18 years of age
  • •Pregnant patients
  • •Patients with ASA-class >3
  • •Patients undergoing treatment for chronic pain with opiates
  • •Patients with biopsy proven gallbladder cancer
  • •Patients who cannot provide consent for the study
  • •Patients not willing to participate in the study
  • •Prisoners/Institutionalized individuals

Arms & Interventions

Single port cholecystectomy

Active Comparator

In brief, a flexible, multi-sleeve 15-mm trocar designed specifically for single-port cholecystectomy will be inserted at the umbilicus via a 15-mm single incision. An additional 2-mm grasping device may be introduced in the right upper quadrant for retraction if necessary; this device is placed percutaneously without the need for a trocar. A 5-mm laparoscopic clip applier will be introduced through the periumbilical trocar to ligate the cystic artery and the cystic duct. The gallbladder will be removed through the umbilical port, adequate hemostasis is ensured, the umbilical trocar removed, and the single operative site will be closed and sterile dressings applied (four Band-Aids).

Intervention: Single-port cholecystectomy (Procedure)

Four-port laparoscopic cholecystectomy

Active Comparator

The control procedure for the research practicum is a four-trocar laparoscopic cholecystectomy, the current gold-standard operation. This approach utilizes a 10-mm trocar placed at the umbilicus via a 15-mm incision and three separate subcostal 5-mm trocars placed via separate 5-mm incisions. The gallbladder will be removed through the umbilical trocar site. On occasion, this incision needs to be enlarged to accommodate removal of the gallbladder. Trocar sites will be closed and sterile dressings applied (four Band-Aids).

Intervention: Four-port laparoscopic cholecystectomy (Procedure)

Outcomes

Primary Outcomes

Pain Scores on the Visual Analog Scale

Time Frame: Baseline to Post Operative day 1

The investigators will utilize the Patient-Reported Outcomes from the VAS to measure changes from Baseline to day 1 post OP. A 15-mm difference on a 100-mm visual analog scale with a standard deviation of 25 mm at any time point will constitute a clinically relevant difference.

Secondary Outcomes

  • Quality of Life (QOL)(up to 7 days)
  • Heart Rate Variability (HRV) Data(During surgery from incision to closure)
  • Cytokine levels in blood(Baseline, during surgery form incision to closure, 1 hour post OP and 4 hour post OP)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Juliane Bingener-Casey

MD

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials